S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › FRVIA › Research report
← FRVIA page
XStocksXray
Market X-Ray report · 19 October 2026

Forvia SE (FRVIA)

Euronext Paris · France · prices in EUR · close of 19 Oct 2026

Key indicators

Last closeEUR 8.974
52-week range8.384 – 15.030
Return, 1 month / 3 months−2.7% / +4.8%
Return, 1 year / 3 years−12.8% / −41.5%
TrendBelow its 200-day average
RSI (14)50
Volatility (1 year)48.6%
Worst drawdown (1 year)-43.2%
Average daily value traded8.18M EUR
Dividend yield–

Market X-Ray price-based

49/ 100 · High confidence · ahead of 46% of stocks on this exchange
Trend31
Momentum55
Risk (lower is better)39
Liquidity89
Income–

Five-year price chart navy: price · brown: 200-day average

3.0313.4723.9134.3544.792021-112023-022024-052025-072026-10

About the company

Forvia is an automotive supplier based in France that makes parts and systems for car manufacturers around the world. Its products include seating, interior trim and dashboards, emissions control and clean mobility systems, and electronics such as lighting and driver-assistance components. It serves major vehicle makers as a tier-one supplier, working with them on components fitted into passenger cars and commercial vehicles.

Forvia SE trades under the code FRVIA on the Euronext Paris in France, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Forvia SE (FRVIA) trades on the Euronext Paris in France. It last closed at EUR 8.974 on 19 October 2026.

Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 337 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 12.8% and over the last three months it rose 4.8%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Forvia SE (FRVIA)

The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris

Lens and metricValueScoreReading
Trend31 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-14.0%
From 52-week high-39.5%
Momentum55 · FairTypical recent returns for this exchange.
3-month return4.8%
6-month return-15.0%
12-month return, skipping the last month-10.4%
Risk (lower is better)39 · WeakVolatile, with deep drawdowns.
Volatility (1 year)48.6%
Worst drawdown (1 year)-43.2%
Liquidity89 · StrongTrades actively.
Average daily value traded8.18M EUR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends1

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Risk (lower is better): Volatile, with deep drawdowns.

Returns

1 week+5.0%
1 month−2.7%
3 months+4.8%
6 months−15.0%
1 year−12.8%
3 years−41.5%
5 years−78.0%

Signals

50-day / 200-day average9.080 / 10.436
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.441

Technical summary

DailyNeutral5 bullish · 4 neutral · 7 bearish
WeeklyStrongly bearish1 bullish · 1 neutral · 10 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

Recent dividends

Ex-dividend dateAmount per share
4 Jun 2024EUR 0.5000
3 Jun 2021EUR 1.0000
31 May 2019EUR 1.2500

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026